Recap: McKesson Q3 Earnings

Shares of McKesson MCK decreased 0.1% in pre-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share rose 20.73% over the past year to $4.60, which beat the estimate of $4.13.

Revenue of $62,599,000,000 up by 5.79% year over year, which beat the estimate of $61,710,000,000.

Looking Ahead

McKesson raised FY21 adjusted EPS forecast from $16.00-$16.50 to $16.95-$17.25.

Conference Call Details

Date: Feb 02, 2021

Time: 08:00 AM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Finvestor.mckesson.com%2F&eventid=2941846&sessionid=1&key=CCAA82CF2B2C3FD8BC8A63DF238E2C78&regTag=&V2=false&sourcepage=register

Price Action

Company's 52-week high was at $187.67

Company's 52-week low was at $112.60

Price action over last quarter: Up 8.41%

Company Description

McKesson is the largest leading third-party logistics providers. The company is engaged in wholesale pharmaceutical and medical products sourcing, distribution and dispensing, contract manufacturing, and related IT services to acute care hospitals and health systems, independent and chain retail pharmacies in North America, Europe, and Canada. Through acquisition and joint ventures McKesson also runs the fourth- largest pharmacy chain and provides technology and consulting services to manufacturers, pharmacies, physician offices, surgery centers, long-term care facilities, and home healthcare businesses.